Flow cytometry is a powerful tool to screen and optimize protein therapeutics. But the raw data is complex and requires preparation before downstream analysis. Performed manually, this process creates a bottleneck for high-throughput approaches.
Facing this challenge, a leading biopharma company looked to increase the throughput of its antibody screening method by streamlining the scientific data workflow.
Read the case study to learn how TetraScience helped this company achieve:
The outcome was faster, better lead identification without increasing instrument footprint or personnel.